News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
236,176 Results
Type
Article (13867)
Company Profile (36)
Press Release (222272)
Multimedia
Podcasts (18)
Webinars (6)
Section
Business (63493)
Career Advice (703)
Deals (15073)
Drug Delivery (34)
Drug Development (32109)
Employer Resources (70)
FDA (5639)
Job Trends (5023)
News (117523)
Policy (9944)
Tag
2027 Pharm Country Standard (1)
Academia (1128)
Academic (1)
Accelerated approval (8)
Adcomms (9)
Allergies (54)
Alliances (17956)
ALS (68)
Alzheimer's disease (610)
Antibody-drug conjugate (ADC) (75)
Approvals (5802)
Artificial intelligence (134)
Autoimmune disease (38)
Automation (11)
Bankruptcy (129)
Best Places to Work (4218)
BIOSECURE Act (6)
Biosimilars (80)
Biotechnology (20)
Bladder cancer (53)
Brain cancer (24)
Breast cancer (229)
Cancer (1578)
Cardiovascular disease (168)
Career advice (604)
Career pathing (14)
CAR-T (82)
CDC (21)
Celiac Disease (1)
Cell therapy (216)
Cervical cancer (13)
Clinical research (28565)
Collaboration (464)
Company closure (1)
Compensation (94)
Complete response letters (12)
COVID-19 (1188)
CRISPR (22)
C-suite (238)
Cystic fibrosis (38)
Data (2479)
Denatured (9)
Depression (44)
Diabetes (207)
Diagnostics (2301)
Digital health (11)
Diversity (8)
Diversity, equity & inclusion (29)
Drug discovery (68)
Drug pricing (64)
Drug shortages (17)
Duchenne muscular dystrophy (76)
Earnings (20861)
Editorial (25)
Employer branding (6)
Employer resources (65)
Events (29833)
Executive appointments (333)
FDA (6718)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (2)
Frontotemporal dementia (5)
Funding (502)
Gene editing (46)
Generative AI (12)
Gene therapy (175)
GLP-1 (376)
Government (1395)
Grass and pollen (3)
Guidances (140)
Healthcare (6775)
HIV (30)
Huntington's disease (12)
IgA nephropathy (23)
Immunology and inflammation (70)
Immuno-oncology (20)
Indications (35)
Infectious disease (1285)
Inflammatory bowel disease (81)
Inflation Reduction Act (6)
Influenza (42)
Intellectual property (69)
Interviews (123)
IPO (7161)
IRA (22)
Job creations (929)
Job search strategy (512)
JPM (17)
Kidney cancer (4)
Labor market (21)
Layoffs (109)
Leadership (17)
Legal (2267)
Liver cancer (30)
Longevity (2)
Lung cancer (180)
Lymphoma (125)
Machine learning (9)
Management (22)
Manufacturing (208)
MASH (76)
Medical device (4571)
Medtech (4590)
Mergers & acquisitions (8536)
Metabolic disorders (474)
Multiple sclerosis (79)
NASH (15)
Neurodegenerative disease (90)
Neuropsychiatric disorders (21)
Neuroscience (1080)
NextGen: Class of 2026 (2600)
Non-profit (1733)
Now hiring (5)
Obesity (192)
Opinion (64)
Ovarian cancer (58)
Pain (70)
Pancreatic cancer (83)
Parkinson's disease (118)
Partnered (15)
Patents (119)
Patient recruitment (140)
Peanut (20)
People (21999)
Pharmaceutical (9)
Pharmacy benefit managers (14)
Phase 1 (6849)
Phase 2 (12447)
Phase 3 (11223)
Pipeline (1744)
Policy (106)
Postmarket research (1212)
Preclinical (2523)
Press Release (30)
Prostate cancer (97)
Psychedelics (16)
Radiopharmaceuticals (104)
Rare diseases (275)
Real estate (1804)
Recruiting (23)
Regulatory (7835)
Reports (20)
Research institute (1006)
Resumes & cover letters (96)
Rett syndrome (2)
RNA editing (1)
RSV (32)
Schizophrenia (72)
Series A (91)
Series B (65)
Service/supplier (2)
Sickle cell disease (41)
Special edition (3)
Spinal muscular atrophy (69)
Sponsored (10)
Startups (1505)
State (1)
Stomach cancer (6)
Supply chain (28)
Tariffs (17)
The Weekly (9)
Vaccines (407)
Venture capital (22)
Weight loss (128)
Women's health (27)
Worklife (8)
Date
Today (23)
Last 7 days (169)
Last 30 days (588)
Last 365 days (9751)
2026 (820)
2025 (10036)
2024 (11700)
2023 (13585)
2022 (17654)
2021 (19990)
2020 (19458)
2019 (17287)
2018 (13330)
2017 (12265)
2016 (11334)
2015 (13916)
2014 (9627)
2013 (7606)
2012 (8193)
2011 (8233)
2010 (7178)
Location
Africa (275)
Alabama (13)
Alaska (4)
Arizona (103)
Arkansas (3)
Asia (15473)
Australia (2727)
California (3359)
Canada (757)
China (399)
Colorado (112)
Connecticut (148)
Delaware (119)
Europe (37650)
Florida (544)
Georgia (141)
Idaho (21)
Illinois (303)
India (21)
Indiana (205)
Iowa (3)
Japan (196)
Kansas (53)
Kentucky (14)
Louisiana (12)
Maine (56)
Maryland (477)
Massachusetts (2167)
Michigan (111)
Minnesota (196)
Mississippi (4)
Missouri (46)
Montana (7)
Nebraska (7)
Nevada (51)
New Hampshire (22)
New Jersey (1105)
New Mexico (9)
New York (1030)
North Carolina (514)
Northern California (1517)
Ohio (104)
Oklahoma (3)
Oregon (7)
Pennsylvania (736)
Puerto Rico (4)
Rhode Island (7)
South America (416)
South Carolina (16)
Southern California (1408)
Tennessee (62)
Texas (605)
United States (12604)
Utah (102)
Vermont (1)
Virginia (87)
Washington D.C. (9)
Washington State (282)
West Virginia (1)
Wisconsin (41)
Wyoming (2)
236,176 Results for "azzur group llc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Genetown
Editas Medicine and Azzur Group Expand Partnership to Accelerate Editas’ Manufacturing Capabilities for Advancing the EDIT-301 Program Through Approval to Commercialization
Editas Medicine, Inc. and Azzur Cleanrooms on Demand™, an Azzur Group company, announced the companies have expanded their multi-year contract to support the scaling of EDIT-301, Editas Medicine’s experimental cell therapy medicine under investigation for the treatment of severe sickle cell disease and transfusion-dependent beta thalassemia, from approval to commercialization.
July 27, 2023
·
5 min read
Press Releases
LSL PHARMA GROUP SUCCESSFULLY OBTAINED U.S. FDA CERTIFICATION FOR THE MANUFACTURING OF OPHTHALMIC OINTMENTS FOR COMMERCIALIZATION IN THE UNITED STATES
January 29, 2026
·
3 min read
Press Releases
CellRight Technologies, LLC Announces Update and Senior Leadership Changes
October 21, 2025
·
3 min read
Press Releases
Secura Bio Announces Participation in Gilmartin Group’s 2026 Corporate Access Event in San Francisco
December 24, 2025
·
4 min read
Press Releases
Victor Miller Joins NorthStar Medical Radioisotopes, LLC as Chief Financial Officer
December 17, 2025
·
3 min read
Press Releases
Allergy Research Group Announces Peer-Reviewed Publication Advancing Thyroid and Endocrine Integration Science
February 5, 2026
·
2 min read
BioCapital
On Demand Pharmaceuticals Announces Preferred Supplier Relationship with Azzur Group
On Demand Pharmaceuticals, Inc., an innovative technology company transforming the way medicines are made, announced that it has signed a Preferred Supplier agreement with Azzur Group through 2024.
June 1, 2022
·
2 min read
Press Releases
Kathy Spencer-Pike Joins NorthStar Medical Radioisotopes, LLC as Chief Commercial Officer
December 17, 2025
·
3 min read
Gene therapy
Liver Toxicities Force Pause on Two Dose Groups of UniQure’s Mid-Stage Fabry Study
The gene therapy uses an AAV vector to restore healthy levels of the alpha-galactosidase enzyme, which is rendered dysfunctional in patients with Fabry disease, leading to the toxic build-up of lipids in cells.
February 9, 2026
·
1 min read
·
Tristan Manalac
Press Releases
Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day
February 3, 2026
·
7 min read
1 of 23,618
Next
